FDA Clears First Topical Form of Minocycline for Acne FDA Clears First Topical Form of Minocycline for Acne

Minocycline topical foam (Amzeeq) is for the treatment of inflammatory lesions of nonnodular moderate to severe acne vulgaris in adults and children aged 9 years or older.FDA Approvals
Source: Medscape FamilyMedicine Headlines - Category: Primary Care Tags: Dermatology News Alert Source Type: news